Overview
- 3 public-safe observations are available for this inspection.
- 3 structured CFR citations are represented.
- 4 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
25 Jun 2026
21 CFR 111.15(b)
Physical plant - clean and sanitary
Cited by Dana A Razzano, Nasser Yazdani, Brenna L MacDowell, Kleever N Soto-Santiago
25 Jun 2026
21 CFR 117.93
Storage and Distribution
Cited by Dana A Razzano, Nasser Yazdani, Brenna L MacDowell, Kleever N Soto-Santiago
25 Jun 2026
21 CFR 1.225
Not registered
Cited by Dana A Razzano, Nasser Yazdani, Brenna L MacDowell, Kleever N Soto-Santiago
Inspected site
TPTrafa Pharmaceutical Inc.Holyoke, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 1.225 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.15(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 117.93 | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 3 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere